The effects of intranasal insufflation of growth hormone releasing factor analogie GRF1 – 29 NH2 on growth hormone secretion in children with short stature

1986 ◽  
Vol 113 (4_Suppl) ◽  
pp. S135-S138 ◽  
Author(s):  
M. BORKENSTEIN
Keyword(s):  
Growth Hormone ◽  
Short Stature ◽  
Gh Deficiency ◽  
Hormone Secretion ◽  
Growth Hormone Secretion ◽  
Normal Children ◽  
Serum Growth Hormone ◽  
Growth Hormone Releasing Factor ◽  
Serum Gh ◽  
Synthetic Growth

ABSTRACT The effects of intranasal insufflation of the synthetic growth hormone releasing factor GRF 1-29-NH2 on serum growth hormone (GH) were investigated in five healthy prepubertal children with short stature. 100 μg/kg/body weight of synthetic GRF 1-29-NH2, 500 μg in 100 μl water, were insufflated intranasally after careful cleaning of the nose. GRF 1-29-NH2 induced a prompt rise of serum GH levels with peak values at 15 minutes in all children investigated. Peak serum GH values were 28.3 ± 12.0 ng/ml (x̄ ± SD), range 17.1 - 47.6 ng/ml; Δ was 27.0 ± 12.2 ng/ml (x̄ ± SD). Serum GH levels were still significantly raised 120 minutes after the insufflation of GRF 1-29-NH2 (p < 0.05). No side effects, except for burning of the nasal mucosa in one patient, were observed. The results of this study demonstrate that intranasal insufflation of synthetic GRF 1-29-NH2 induces a prompt release of GH in otherwise normal children with short stature. Pulsatile intranasal insufflation of GRF 1-29-NH2 probably could be used for the treatment of some children with GH deficiency due to a defect at a suprapituitary level.

scholarly journals Effect of Synthetic Growth Hormone-Releasing Factor from a Human Pancreatic Tumor on Bovine and Caprine Growth Hormone Secretion

1984 ◽  
Vol 55 (1) ◽  
pp. 66-68
Author(s):  
Koichi HODATE ◽  
Tetsu JOHKE ◽  
Asao KAWABATA ◽  
Shinichi OHASHI ◽  
Masaru SHIRAKI ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Pancreatic Tumor ◽  
Hormone Secretion ◽  
Growth Hormone Secretion ◽  
Growth Hormone Releasing Factor ◽  
Synthetic Growth

Pituitary volume in children with growth hormone deficiency, idiopathic short stature and controls

2016 ◽  
Vol 29 (10) ◽  
Author(s):  
Marion Kessler ◽  
Michael Tenner ◽  
Michael Frey ◽  
Richard Noto
Keyword(s):  
Growth Hormone ◽  
Magnetic Resonance ◽  
Growth Hormone Deficiency ◽  
Short Stature ◽  
Hormone Secretion ◽  
Growth Hormone Secretion ◽  
Magnetic Resonance Images ◽  
Idiopathic Short Stature ◽  
Hormone Deficiency ◽  
Significant Difference

AbstractBackground:The objective of the study was to describe the pituitary volume (PV) in pediatric patients with isolated growth hormone deficiency (IGHD), idiopathic short stature (ISS) and normal controls.Methods:Sixty-nine patients (57 male, 12 female), with a mean age of 11.9 (±2.0), were determined to have IGHD. ISS was identified in 29 patients (20 male, 9 female), with a mean age of 12.7 (±3.7). Sixty-six controls (28 female, 38 male), mean age 9.8 (±4.7) were also included. Three-dimensional (3D) magnetic resonance images with contrast were obtained to accurately measure PV.Results:There was a significant difference in the mean PV among the three groups. The IGHD patients had a mean PV 230.8 (±89.6), for ISS patients it was 286.8 (±108.2) and for controls it was 343.7 (±145.9) (p<0.001). There was a normal increase in PV with age in the ISS patients and controls, but a minimal increase in the IGHD patients.Conclusions:Those patients with isolated GHD have the greatest reduction in PV compared to controls and the patients with ISS fall in between. We speculate that a possible cause for the slowed growth in some ISS patients might be related to diminished chronic secretion of growth hormone over time, albeit having adequate pituitary reserves to respond acutely to GH stimulation. Thus, what was called neurosecretory GHD in the past, might, in some patients, be relative pituitary hypoplasia and resultant diminished growth hormone secretion. Thus, PV determinations by magnetic resonance imaging (MRI) could assist in the diagnostic evaluation of the slowly growing child.

EFFECTS OF STILBOESTROL ON GROWTH HORMONE SECRETION AND PITUITARY CELL PROLIFERATION IN THE MALE RAT

1971 ◽  
Vol 51 (3) ◽  
pp. 473-481 ◽  
Author(s):  
H. M. LLOYD ◽  
J. D. MEARES ◽  
JOAN JACOBI ◽  
FRANCES J. THOMAS
Keyword(s):  
Growth Hormone ◽  
Cell Proliferation ◽  
Mitotic Activity ◽  
Hormone Secretion ◽  
Growth Hormone Secretion ◽  
Mean Value ◽  
Pituitary Cell ◽  
Male Rats ◽  
Male Rat ◽  
Serum Growth Hormone

SUMMARY A single 12 mg dose of stilboestrol dipropionate given to 100-day-old male rats resulted in increased pituitary mitotic activity, pituitary weight and serum growth hormone; the latter rose from a mean value of 20 ng/ml to a maximum of 342 ng/ml 9 days later. Serum growth hormone and pituitary mitotic activity then gradually diminished but were still slightly increased on day 28. Serum growth hormone and pituitary weight were significantly correlated during the periods of rapidly rising and of sustained high levels of serum growth hormone. Indices of mitotic activity were correlated with serum growth hormone during the periods of rapidly rising and of falling levels of serum growth hormone.

Sign in / Sign up

Export Citation Format

Share Document